Reflections from the private (and public) fundraising frontlines at a start-up investigating the use of psychedelics (like psilocybin, an active ingredient in so-called ‘magic mushrooms’) to transform mental health care at scale. Until October last year, I was VP of Operations at COMPASS Pathways, a mental health care company dedicated…